
Drugs developed to slow the progression of Alzheimer and #39;s disease may have a much smaller impact than initially hoped, according to a recent analysis carried out under the auspices of Cochrane.
Informatie preluata din publicatia "Bursa" - citeste integral articolul - click aici
Web Design by Dow Media | Gazduire Web by SpeedHost.ro